Avita Medical | Koszty Sprzedaży I Administracji



Selling And Administration Expenses Zmiana Data
Adcock Ingram Holdings ZAR 997.56M 6.08M 2024-06
Celltrion KRW 239.71B 17.94B 2024-09
Clinuvel Pharmaceuticals AUD 16.21M 3.62M 2024-06
Cochlear AUD 465.6M 33.6M 2024-06
CSL USD 1.38B 341M 2024-06
Cspc Pharmaceutical CNY 2.1B 22.82M 2024-09
Dianthus Therapeutics USD 6.83M 287K 2024-12
Ecofibre AUD 8.03M 1.38M 2024-06
Kangmei Pharma CNY 245.26M 66.07M 2024-09
Knight Therapeutics CAD 25.48M 119K 2024-09
Laboratorios Farma EUR 32.57M 26.69M 2024-06
Malin Corporation EUR 700K 1.6M 2024-06
Mayne Pharma AUD 54.8M 11.94M 2024-06
Medical Developments International AUD 7.07M 15.4M 2024-06
Nanosonics AUD 24.09M 20.53M 2024-06
Neuren Pharmaceuticals AUD 2.33M 47K 2024-12
Organigram Holdings CAD 17.19M 2.88M 2024-12
Pacific Edge NZD 19.43M 12.04M 2024-09
Paradigm Biopharmaceuticals AUD 3M 774.85K 2024-06
Pharma Mar EUR 13.68M 450K 2025-03
Polynovo AUD 21.13M 18.27M 2024-06
PYC Therapeutics AUD 1.01M 851.93K 2024-06
Qiagen NV USD 141.71M 1.05M 2024-12
Ramsay Health Care AUD 5.29B 3.2M 2024-12
ResMed USD 241.61M 2.63M 2024-12
Sartorius EUR 231.9M 13.6M 2025-03
Sino Biopharmaceutical CNY 5.31B 1.89B 2024-12
Telix Pharmaceuticals AUD 87.69M 29.72M 2024-06
Tilray USD 72.38M 4.99M 2024-11
Zz Pientze Pharmaceu 168.44M 20.66M 2024-09



Avita Medical Koszty Sprzedaży I Administracji - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Apr 2025.